Preparations containing the ingredient and / or extracts of Eperua-FarukataBeauty containing extract plant Eperua-Farukata of (Eperua falcata), the active ingredient, the Engerechin or astilbin, the present invention relates to a skin preparations or pharmaceutical.フロランスアンリ...
Injections comprise aqueous solutions of the active ingredient containing buffers such as citric acid to produce a pH of 3.5 to 5.0, preservatives and anti-oxidants such as formaldehyde sodium bisulphite, sodium bisulphite, sodium sulphite and ascorbic acid, a mixture of the last three being ...
Hydrophilic drug preparations containing nateglinide B crystals useful as a hypoglycemic agent as the active ingredient which comprise a hydrophilic substance selected from the group consisting of hydrophilic polymers, surfactants, sugar... NCACI Ninomiya,MAKINO, Chisato,c/o Ajinomoto Co., Inc,YABUKI, ...
Duromine is one of many appetite suppressant drugs containing the active ingredient, Phentermine. Due to their effectiveness and rapid results, these medications are used to control obesity in Australia and New Zealand. Phentermine is available in a range of dosages and is approved by the FDA. It...
solutions of colophonium in alcohol, polyvinyl pyrrolidone or polyethylene glycol. Examples describe preparations containing as active ingredient (a) orphenadrine, (b) orphenadrine citrate, (c) physostigmine salicylate and (d) ephedrine hydrochloride. 展开 ...
How to make callus for Queen of the Night, and ext 优质文献 相似文献An iodopropargyl carbamate derivative, a method for its production and fungicidal compositions containing it as an active ingredient A compound having fungicidal activity is represented by the general formula, wherein X, which may...
Pesticides containing formimidoesters. CIBA Ltd. 27 March, 1968 [28 March, 1967], No. 14706/68. Heading A5E. [Also in Division C2] Pesticidal preparations especially preparations for combatting insects, arachnoids and nematodes comprises at the active ingredient at least one formimido-ester of ...
tions of suitable size and shape, designed to be inserted in the conjunctival sac, to produce an ocular effect. they gener- ally consist of a reservoir of active ingredient embedded in a matrix or bounded by a rate-controlling membrane. the ac- tive ingredient, which is more or less ...
Among those deregulated by ADAPT-232, there were 206 genes that were not deregulated by any ingredient of BHP ADAPT-232 due to the synergy effect (Figure 7). The synergy-derived biological effect is characteristic of the BHP (ADAPT-232), which has a distinct pharmacological profile (signature...
Date Jan. 12, 1995The invention relates to a novel pharmaceutical preparation, containing an active ingredient of at least one active amidine group, which contains a pharmaceutically active amidine group which may be a administered orally. The amidine group is present in the form of a compound ...